Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of CPD gene polymorphisms on weight and fat mass reduction by perindopril in obese subjects
2015-004275-70Phase 2Terminated
- Sponsor
- Gene PreDiT
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of perindopril in obesity, sponsored by Gene PreDiT. Primary endpoint: Primary response rate. Started Dec 2015; status: terminated.
02
Drugs
perindopril
03
Conditions
obesity
Beyond the preview
Go deeper on 2015-004275-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004275-70.